Discover
TTRX
Turn Therapeutics Inc.
10.22
1 x 10.20
1 x 10.37
bid
ask
+
0.62
6.46%
undefined @ 04:00 PM
10.22 +0.00 (0.00%)
| Ytd | 159.39% | |
| 1y | 46.00% |
9.63
day range
10.57
2.57
52 week range
26.50
| Open | 9.75 | Prev Close | 9.60 | Low | 9.63 | High | 10.57 | Mkt Cap | 304.43M |
| Vol | 0.00 | Avg Vol | 82.07K | EPS | -0.19 | P/E | -53.79 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 7.67 | 200-d Avg | 4.80 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.25M | ||
| Research and Development Expense | 109.43K | ||
| Selling, General and Administrative Expense | 1.14M | ||
| Operating Income | -1.25M | ||
| Net Income | -970.97K | ||
| Net Income Common Stock | -970.97K | ||
| Net Income Common Stock (USD) | -970.97K | ||
| Consolidated Income | -970.97K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -970.97K | ||
| Earning Before Interest & Taxes (USD) | -970.97K | ||
| Weighted Average Shares | 29.48M | ||
| Weighted Average Shares Diluted | 29.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.22M | ||
| Cash and Equivalents (USD) | 11.22M | ||
| Current Assets | 11.45M | ||
| Property, Plant & Equipment Net | 67.57K | ||
| Total Assets | 18.64M | ||
| Debt Current | 47.80K | ||
| Total Debt | 6.01M | ||
| Current Liabilities | 5.13M | ||
| Debt Non-Current | 5.96M | ||
| Total Liabilities | 12.53M | ||
| Accumulated Retained Earnings (Deficit) | -23.36M | ||
| Shareholders Equity | 6.12M | ||
| Shareholders Equity (USD) | 6.12M | ||
| Assets Non-Current | 7.19M | ||
| Total Debt (USD) | 6.01M | ||
| Deferred Revenue | 1.44M | ||
| Goodwill and Intangible Assets | 919.95K | ||
| Liabilities Non-Current | 7.40M | ||
| Trade and Non-Trade Payables | 2.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.45K | ||
| Net Cash Flow from Financing | 7.79M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.14M | ||
| Issuance (Purchase) of Equity Shares | 1.07M | ||
| Issuance (Repayment) of Debt Securities | 6.72M | ||
| Net Cash Flow from Investing | -12.23K | ||
| Net Cash Flow from Operations | -1.63M | ||
| Share Based Compensation | 280.83K | ||